1.. INTRODUCTION
================

Stroke is one of the most severe diseases which is a leading cause of death around the world. Cerebral ischemic stroke has been accounted for approximately 80% of all strokes \[[@r1], [@r2]\]. It suggests that the occlusion of a blood vessel by a thrombus, resulting in an immediate loss of the normal supply of oxygen and glucose to cerebral tissue, is the most common cause of ischemic stroke \[[@r3], [@r4]\]. Currently, several of therapeutic strategies are currently being considered as a means of minimizing the neuronal damage resulting from ischemia, leading to investigate the pathological mechanisms underlying stroke. The oxidative stress has been shown to severely impact the nervous system during the stroke through the generation of reactive oxygen species (ROS), which can result in mitochondrial dysfunction, the loss of DNA integrity, and the misfolding of proteins. The kinase cascade including phosphoinositide 3 kinase (PI3K), protein kinase B (Akt), and the mammalian target of rapamycin (mTOR) involved in oxidative stress in the nervous system, offers exciting prospects for the development of novel and safe clinical treatment avenues for nervous system disorders \[[@r5]-[@r7]\].

Danshen is a very important component of Chinese medicine derived from the dried root or rhizome of Salviae miltiorrhizae Bge. The danshen has been widely used in China for the treatment of cerebrovascular conditions in recent years, such as ischemic stroke \[[@r8]\]. Tanshinone IIA is a key active component of danshen \[[@r9]\]. Recent studies have demonstrated that tanshinone IIA has been shown to have protective effects against focal cerebral ischemia/reperfusion (I/R) injury in animal models \[[@r10]-[@r12]\]. Several studies reported that tanshinone IIA could protect against oxidative stress and cell death by significantly decreasing ROS levels in different system \[[@r13]-[@r16]\]. However, the mechanisms underlying tanshinone IIA-mediated protective effects on the cerebral I/R injury are still unclear. Therefore, the present study was intended to evaluate the potentially protective effects of tanshinone IIA in a stroke model *in vitro* and illuminate the involved mechanisms.

2.. MATERIALS AND METHODS
=========================

2.1.. Materials
---------------

Tanshinone IIA was bought from aladdin reagents (Shanghai, China).Dulbecco\'s modified Eagle\'s medium (DMEM) and fetal bovine serum (FBS) were obtained from GIBCO (Los Angeles, CA); Antibodies that including anti-phosphorylated Akt, and anti- phosphorylated p85 were obtained from Cell Signaling (Danvers, MA); anti-B cell lymphoma/lewkmia-2 Associated X protein (Bax), anti- Microtubule-associated protein 1A/1B-light chain 3(LC3) and anti- glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibodies were bought from Abcam (Cambridge, UK); Lipofectamine RNAiMAX was purchased from Invitrogen (Carlsbad, CA); Fluorogenic probe 5-(and-6)-chloromethyl-2\',7\'-dichlorodihydrofluorescein diacetate acetyl ester (CM-H2DCFDA) (Invitrogen, Eugene, OR); 5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine,iodide (JC-1) probe (Invitrogen, Carlsbad, CA); The small interfering RNAs (siRNAs) of mice protein kinase B (Akt),mammalian target of Rapamycin (mTOR) were synthesized by Gene Pharma (Shanghai, China).

2.2.. Cell Culture and Transfection
-----------------------------------

HT-22 cells (an immortalized mouse hippocampal cell line) were bought from Fu Xiang Biotech (Shanghai, China). HT-22 cells were cultured at 37 °C and 5% CO~2~ in DMEM with 10% heat-inactivated FBS. Transient transfection with siRNAs of Akt and mTOR was performed with using Lipofectamine RNAiMAX according to the manufacturer\'s procedures.

2.3.. Oxygen and Glucose Deprivation/Reperfusion (OGD/R)
--------------------------------------------------------

The model for oxygen and glucose deprivation/ reperfusion (OGD/R) was established using the anaeropack method as described previously \[[@r17]\]. Briefly, HT-22 cells were cultured in glucose-free DMEM and then placed inside a sealed air tight container which contains an anaeropack (Mitsubishi Gas Company, Tokyo, Japan), which resulted in a hypoxic atmosphere by absorbing oxygen and generating carbon dioxide. The cells were maintained in hypoxic conditions at 37°C for 6 hours. Thereafter, the medium was discarded, normal DMEM with glucose was added and culturing continued for 6-24 hours of reoxygenation under normoxic condition to produce OGD/R. HT-22 cells cultured in growth culture medium under normoxic condition served as a control.

2.4.. Cell Viability Assay
--------------------------

The HT-22 cells (1×10^4^ cells/well) were seeded in 96-well plates with 100 µl culture medium, and were incubated for overnight to allow the cells to attach to the bottom of the plate. The cell viability was analyzed with a microplate reader using cell counting kit-8 (CCK-8, Dojindo, Japan) following the treatments. The treatments included the tanshinone IIA (0.2, 1, 2 and 5 ug/ml) treatments, LY294002 (10 μM) adding and mTOR, Akt siRNAs transfection.

2.5.. Measurement of Intracellular Reactive Oxygen Species (ROS) Production
---------------------------------------------------------------------------

Intracellular ROS levels used the CM-H2DCFDA staining. HT-22 cells were seeded onto 96-well plates similar to the cell viability test. After the indicated treatments, cultured medium were removed and incubated for 30 minutes with CM-H2DCFDA (10 µM) in DMEM. The cells were then washed twice with phosphate buffer saline (PBS) and ROS was visualized by fluorescence microscopy and quantified by a microplate reader (485 nm/528 nm).

2.6.. Mitochondrial Membrane Potential (MMP) Analysis
-----------------------------------------------------

Mitochondrial membrane potential was determined using JC-1 probe. HT-22 cells were seeded in 96-well plates similar to the cell viability test. After treatments, cultured medium were removed, and incubated for 30 min with 10 µg /ml of JC-1 dye (Invitrogen). The cells were washed, visualized and quantified by the fluorescence microscopy and microplate reader (485 nm/535 nm).

2.7.. Immunofluorescence Staining
---------------------------------

The immunofluorescence assays were performed with the methods we described previously \[[@r18]\]. Briefly, cells were incubated in 4% paraformaldehyde (PFA) for 10 minutes. The LC3 II antibody was then applied at an optimal concentration (1:100) overnight in a wet chamber. The cells were rinsed in PBS and incubated with the secondary antibodies. After washing three times with PBS, the secondary antibody conjugated to Alexa Fluor 488 was applied to these slides for 1 hour at room temperature. The nuclei were counterstained with 4', 6-diamidino-2-phenylindole (DAPI).

2.8.. Western-blot Assay
------------------------

After treatments, the protein was extracted from HT-22 cells using the radio-immunoprecipitation assay (RIPA) buffer with protease inhibitor cocktail (Pierce). The soluble fraction of the cell lysates was isolated by centrifugation at 12, 000 g for 10 minutes in a microfuge. Bicinchoninic acid (BCA) reagent (Pierce, Rockford, IL, USA) was applied to determine protein concentration. The equal amounts of proteins (30ug/well) were separated by 4-12% dodecyl sulfate, sodium salt (SDS)-Polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to nitrocellulose membranes. The membranes were incubated overnight at 4°C with primary antibodies as following: anti-Akt (ser 473), anti-p85, anti-mTOR, anti-Bax, anti-LC3 and anti-GAPDH. After incubation, the membranes were washed with PBS (containing 0.1% Tween) and incubated with horseradish-peroxidase conjugated detected the antigen-antibody complexes using an electrochemiluminescence (ECL) Plus chemiluminescence reagent kit (Pierce, Rockford, IL, USA).

2.9.. Statistical Analysis
--------------------------

Values are expressed as the mean±Standard Deviation (SD). The significance of differences between two groups was assessed by Student\'s t-test. Experiments have more than two groups and different doses, a dose response analysis was using the one way Analysis of Variance (ANOVA). P\< 0.05 was considered significant.

3.. RESULTS
===========

3.1.. Tanshinone IIA Inhibits OGD/R-mediated Cell Death in HT-22 Cells
----------------------------------------------------------------------

Tanshinone IIA is one of the key components from the Chinese herb Danshen (Radix Salviae Miltiorrhiza Bge) (Fig. **[1](#F1){ref-type="fig"}**). In this study, we firstly established an *in vitro* experimental model of OGD/R using the anaeropack as described previously \[[@r17]\]. HT-22 cells subjected to 6-hours of oxygen and glucose deprivation followed by 6-hours reoxygenation (OGD6/R6) showed a statistically significant 50% decrease in proliferation compared to the normoxia cells (Fig. **[2](#F2){ref-type="fig"}**). We further treated the HT-22 cells with different concentrations of tanshinone IIA (0.2-5 µg/ml) following 6-hours of OGD. It showed that treatment of the cells with tanshinone IIA significantly suppressed the OGD6/R6-mediated cell death (Fig. **[2](#F2){ref-type="fig"}**).

3.2.. Tanshinone IIA Suppresses OGD/R-Increased Intracellular ROS Production in HT-22 Cells
-------------------------------------------------------------------------------------------

It has been demonstrated that the intracellular ROS production could be induced by OGD/R \[[@r19]\]. We thus evaluated whether tanshinone IIA inhibited OGD/R-mediated cell death through controlling oxidative stress response. To this end, we determine the intracellular ROS production using CM-H2DCFDA probe (CM-H2DCFDA can be oxidized from H2DCF to DCF, which is green fluorescence). As shown in [Fig. (**3**)](#F3){ref-type="fig"}, treatment with tanshinone IIA significantly suppressed the intracellular ROS production following reoxygenation (Fig. **[3](#F3){ref-type="fig"}**).

3.3.. Tanshinone IIA Suppresses OGD/R-Reduced the Mitochondrial Membrane Potential in HT-22 Cells
-------------------------------------------------------------------------------------------------

ROS production is known a reason that can cause mitochondrial injury and to disrupt mitochondrial membrane potential (MMP). We here measured MMP using JC-1 staining. The red fluorescence indicates JC-1 existed in the aggregated form in mitochondrial membranes at resting potential. The green fluorescence indicates the existence of free JC-1 at the depolarized MMP. As shown in [Fig. (**4**)](#F4){ref-type="fig"}, the green fluorescence associated with reduction of MMP was markedly suppressed by tanshinone IIA (Fig. **[4](#F4){ref-type="fig"}**).

3.4.. Tanshinone IIA Suppresses OGD/R-Caused Autophagy in HT-22 Cells
---------------------------------------------------------------------

Oxidative stress can activate neural cells autophagy, which helps to break down macromolecules and recycle their components to preserve cellular energy and clear damaged proteins and mitochondria. We here further investigated whether tanshinone IIA exerted its neuroprotection by inhibiting autophagic cell death. As shown in Fig. **[5](#F5){ref-type="fig"}**, tanshinone IIA treatment decreased the OGD/R-mediated LC3 II expression in HT-22 cells (Fig. **[5](#F5){ref-type="fig"}**). The PI3K/Akt/ mTOR axis plays important roles in autophagy inhibition. It showed that tanshinone IIA activated the PI3K/Akt/mTOR signal pathway by increased key components of this pathway, including the p85, Akt and mTOR (Fig. **[5](#F5){ref-type="fig"}**).

3.5.. PI3K/Akt/mTOR Signals are Involved in Tanshinone IIA-mediated Protective Effects in OGD/R-Mediated HT-22 Cell Death
-------------------------------------------------------------------------------------------------------------------------

Based on our hypothesis that PI3K/Akt/mTOR are involved in tanshinone IIA-mediated protective role in OGD/R-mediated neural injury, we thus transfected siRNAs that were specific to mTOR or Akt into the HT-22 cells, or treated HT-22 cells with LY294002, and then exposure to OGD6/R6. As shown in [Fig. (**6**)](#F6){ref-type="fig"}, the viability of cells with tanshinone IIA treatment exceeded that of ODG6/R6 treated cells, but cells transfected with Akt siRNA, mTOR siRNA or LY294002 counteracted the effects of tanshinone IIA (Fig. **[6](#F6){ref-type="fig"}**).

3.6.. Tanshinone IIA Counteracts OGD/R-Increased Intracellular ROS Levels and Reduced MMP *via* PI3K/Akt/mTOR Pathway
---------------------------------------------------------------------------------------------------------------------

In order to determine whether PI3K/Akt/mTOR pathway participated in the OGD/R-associated changes of intra- cellular ROS levels and MMP, we interfered PI3K/Akt/ mTOR pathway using LY294002 treatment or transfected siRNAs of mTOR and Akt into HT-22 cells and stained  them with CM-H2DCFDA and JC-1. As shown in [Fig. (**7**)](#F7){ref-type="fig"}, the HT-22 cells transfected siRNAs of mTOR and Akt,  and LY294002 treatment showed significantly higher intracellular ROS production as compared to the cells with tanshinone IIA treatment (Fig. **[7](#F7){ref-type="fig"}**). Similarly, the HT-22 cells transfected siRNAs of mTOR and Akt, and LY294002 treatment also increased the tanshinone IIA-mediated reduction of the MMP (Fig. **[8](#F8){ref-type="fig"}**).

3.7.. Tanshinone IIA Inhibits OGD/R-Caused Autophagy in HT-22 Cells *via* Activating PI3K/Akt/mTOR Pathway
----------------------------------------------------------------------------------------------------------

We here investigated whether PI3K/Akt/mTOR pathway activation is vital to tanshinone IIA-mediated inhibitory  role in OGD/R-caused autophagy in HT-22 cells. As shown  [Fig. (**9**)](#F9){ref-type="fig"}, the the HT-22 cells transfected siRNAs of mTOR and Akt, and LY294002 treatment abrogated the effects that tanshinone IIA-mediated reduction OGD/R-mediated LC3 II expression (Fig. **[9](#F9){ref-type="fig"}**). The results of western-blots showed that tanshinone IIA treatment could activate the PI3K/ Akt/mTOR pathway by increased expression of pp85, p-akt and p-mTOR, and repressed the LC3 II expression (Fig. **[9](#F9){ref-type="fig"}**).

4.. DISCUSSION
==============

OGD/R is a classical model of cerebral ischemia *in vitro* \[[@r20], [@r21]\]. In this study, we have shown that tanshinone IIA can reduce oxidative stress, apoptosis and autophagy that induced by OGD/R treatment in HT-22 cells. We also demonstrated that tanshinone IIA provided neuronal protection partly through the activation of PI3K/Akt/mTOR signal pathway.

Danshen is a very important traditional Chinese medicinal herb that has been commonly used in traditional Chinese medicine practice for many years in the treatment of coronary artery disease and cerebrovascular diseases including stroke \[[@r4], [@r22]\]. In recent decades, the tanshinone IIA has been widely used in research for the treatment of cerebrovascular disease and has limited or no adverse effects \[[@r12], [@r23], [@r24]\]. In this study, we found that tanshinone IIA could suppress the OGD/R-caused cell death *via* the inhibition of apoptosis and autophagy.

ROS are generated during I/R which are associated with the burst of ROS generation after reperfusion \[[@r25]\]. In this study, the data we presented here demonstrated that tanshinone IIA significantly inhibited OGD/R-caused ROS production in hippocampal neural HT-22 cells. In addition to, an increase in ROS production could cause a reduction of mitochondrial membrane potential and autophagy after exposure to OGD6/R. The PI3K/Akt signaling pathway plays a central role in cell growth and survival. Signaling by PI3K downstream of growth factor receptors is required to suppress apoptosis and to stimulate cell proliferation in most mammalian cell type. Tanshinone IIA protects the different organs or tissues from oxidative stress injury through the PI3K/Akt pathway \[[@r13], [@r26]-[@r31]\]. We here showed that tanshinone IIA could protect HT-22 cell from oxidative stress injury by activating the PI3K/Akt signaling.

Downstream components of PI3K/Akt signaling include the protein kinase mTOR, which is a key regulator of autophagy \[[@r32], [@r33]\]. Autophagy is a highly conserved metabolic process that permits the degradation and recycling of cellular constituents. The induction of autophagy is seen in mouse striatum and cortex after hypoxic-ischemic injury, and oxidative stress following cerebral hypoxia-ischemia may induce autophagy, which initially aborts apoptosis by eliminating damaged mitochondria and preventing necrosis *via* catabolic energy production \[[@r26], [@r34]-[@r36]\]. Upstream of mTOR the survival PI3K/AKT pathway modulates mTOR activity that is altered in neurodegenerative diseases and cancer \[[@r37]\]. However, it is unknown whether tanshinone IIA can inhibit OGD/R-caused autophagy through inhibiting PI3K/Akt/mTOR pathway in neural cells. The study clearly demonstrated that tanshinone IIA activated the PI3K/Akt/ mTOR pathway, resulting in the reduction of autophagy marker LC3 II expression and cell death in OGD/R model.

CONCLUSION
==========

Taken together, the present study indicates that the tanshinone IIA might protect neurons through inhibiting apoptosis and autophagy evoked by oxidative stress. These findings have partially revealed the molecular mechanisms underlying neuroprotection of tanshinone IIA. However, we could not exclude the possibility that tanshinone IIA may undergo neuroprotective activities through other pathways. Other supportive experiments need to be performed for further investigation.
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![The structure of tanshinone IIA.](CNR-14-132_F1){#F1}

![**Protective effect of tanshinone IIA against cell death caused by OGD6/R6.** As expected, the CCK-8 proliferative analysis indicated OGD6/R6 caused HT-22 cell death significantly (Normal versus OGD6/R6, 1.37±0.12 versus 0.70±0.10) (**A**), but this effect is effectively counteracted by tanshinone IIA treatment(0.2-5μg/ml) (**B**). \*, p\<0.05,\*\*p\<0.01.](CNR-14-132_F2){#F2}

![**The tanshinone IIA treatment inhibits OGD/R-increased intracellular reactive oxygen species (ROS).** Tanshinone IIA treatment significantly suppresses the OGD6/R6-increased the intracellular ROS that were detected with a CM-H2DCFDA probe. Representative photographs of fluorescence (**A**). The fluorescence is determined at 485/528 nm (**B**). Scale bar represents 50 µm. \*\*p\<0.01.](CNR-14-132_F3){#F3}

![**Effect of tanshinone IIA treatment on mitochondrial membrane potential (MMP).** Tanshinone IIA inhibited decreasing of OGD6/R6-increased MMP that was detected by a JC-1 assay. Representative photographs of fluorescence (**A**). Quantification of the fluorescence (**B**) Scale bar represents 50 µm. \*\*p\<0.01.](CNR-14-132_F4){#F4}

![**Effect of tanshinone IIA on OGD/R-caused autophagy in HT-22 cells.** Tanshinone IIA inhibited significantly inhibited the expression of Bax and LC3 II but promoted expression of p85, mTOR and Akt (The main components of PI3K/Akt/mTOR pathway). Representative photographs of fluorescence for the autophagy marker LC 3II (**A**). Western-blots analysis (**B**) Scale bar represents 50 µm.](CNR-14-132_F5){#F5}

![**PI3K/Akt/mTOR pathway is essential to tanshinone IIA-mediated protective effects in OGD/R-mediated HT-22 cell death.** The CCK-8 assay showed that tanshinone IIA treatment increased the viability of HT-22 cells in OGD/R model, but this effect was abrogated by mTOR siRNA, Akt siRNA transfection or LY294002 treatment. \*\*p\<0.01.](CNR-14-132_F6){#F6}

![**Effects of PI3K/Akt/mTOR pathway on the tanshinone IIA-suppressed intracellular ROS.** The mTOR siRNA, Akt siRNA transfection or LY294002 treatment disrupted the inhibitory role of tanshinone IIA in OGD/R-mediated ROS production. Representative photographs of fluorescence (**A**). The fluorescence is determined at 485/528 nm (**B**). Scale bar represents 50 µm. \*\*p\<0.01.](CNR-14-132_F7){#F7}

![**Roles of PI3K/Akt/mTOR pathway on the tanshinone IIA-decreased MMP.** The mTOR siRNA, Akt siRNA transfection or LY294002 treatment abrogated the effects of tanshinone IIA on OGD/R-mediated MMP decreasing. Representative photographs of fluorescence (**A**). Quantification of the fluorescence (**B**) Scale bar represents 50 µm. \*\*p\<0.01.](CNR-14-132_F8){#F8}

![**Effect of PI3K/Akt/mTOR pathway on tanshinone IIA-reduced autophagy in HT-22 cells.** The mTOR siRNA, Akt siRNA transfection or LY294002 treatment increased expression of LC3 II in the presence of tanshinone IIA, which suggests tanshinone IIA inhibited autophagy was dependent on the PI3K/Akt/mTOR pathway. Representative photographs of fluorescence (A). Western-blots analysis (B) Scale bar represents 50 µm.](CNR-14-132_F9){#F9}
